Per Business Quant data, Nika Pharmaceuticals insiders hold 455.59Mn shares in total based on their latest Form 4 filings, or 43.32% of the 1.05Bn shares outstanding; that total is unchanged from the end of Q2 2026 and Q3 2025.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Dimitar Slavchev Savov | Ceo, Cfo, President | 455,589,500 | 0 | 455,589,500 | 100.0% | 19 Mar, 2025 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 18 Mar, 2025 | Dimitar Slavchev Savov | Ceo, Cfo, President | Disposed S | 2,000,000 | $0.25 | $500.00K | 455,589,500 | Direct |